Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124539422 | 12453942 | 2 | F | 2016 | 20160715 | 20160609 | 20160720 | EXP | JP-UCBSA-2016020679 | UCB | 65.00 | YR | F | Y | 48.60000 | KG | 20160720 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124539422 | 12453942 | 1 | PS | E Keppra | LEVETIRACETAM | 1 | Intravenous drip | 250 MG, 2X/DAY (BID) | N | 21872 | 250 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | BID | |||||
| 124539422 | 12453942 | 2 | SS | GASTER | FAMOTIDINE | 1 | Intravenous (not otherwise specified) | 20 MG, 2X/DAY (BID) | N | U | 0 | 20 | MG | INJECTION | BID | ||||
| 124539422 | 12453942 | 3 | C | Ropion | FLURBIPROFEN AXETIL | 1 | Intravenous (not otherwise specified) | 50 MG, UNK | U | 0 | 50 | MG | INJECTION | ||||||
| 124539422 | 12453942 | 4 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 10 MG, ONCE DAILY (QD) | U | 0 | 10 | MG | QD | ||||||
| 124539422 | 12453942 | 5 | C | LASIX | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 5 MG, 2X/DAY (BID) | U | 0 | 5 | MG | BID | ||||||
| 124539422 | 12453942 | 6 | C | Dexart | DEXAMETHASONE SODIUM PHOSPHATE | 1 | Intravenous (not otherwise specified) | 3.3 MG, 2X/DAY (BID) | U | 0 | 3.3 | MG | INJECTION | BID | |||||
| 124539422 | 12453942 | 7 | C | Maintate | BISOPROLOL FUMARATE | 1 | Oral | 2.5 MG, ONCE DAILY (QD) | U | 0 | 2.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124539422 | 12453942 | 1 | Epilepsy |
| 124539422 | 12453942 | 2 | Product used for unknown indication |
| 124539422 | 12453942 | 3 | Product used for unknown indication |
| 124539422 | 12453942 | 4 | Product used for unknown indication |
| 124539422 | 12453942 | 5 | Product used for unknown indication |
| 124539422 | 12453942 | 6 | Product used for unknown indication |
| 124539422 | 12453942 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124539422 | 12453942 | DE |
| 124539422 | 12453942 | LT |
| 124539422 | 12453942 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124539422 | 12453942 | Brain neoplasm | |
| 124539422 | 12453942 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124539422 | 12453942 | 1 | 20160516 | 20160526 | 0 | |
| 124539422 | 12453942 | 2 | 20160426 | 20160527 | 0 | |
| 124539422 | 12453942 | 3 | 20160506 | 20160527 | 0 | |
| 124539422 | 12453942 | 4 | 20160426 | 20160527 | 0 | |
| 124539422 | 12453942 | 5 | 20160509 | 20160527 | 0 | |
| 124539422 | 12453942 | 6 | 20160426 | 20160527 | 0 | |
| 124539422 | 12453942 | 7 | 20150624 | 20160604 | 0 |